Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 2
2(66.7%)
Phase 1
1(33.3%)
3Total
Phase 2(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03098628Phase 2Completed

Trial of Simplified Pneumococcal Vaccination in Vietnam II

Role: collaborator

NCT03922594Terminated

Surveillance of Zika-related Microcephaly in Sub-Saharan Africa and Asia

Role: collaborator

NCT03095599Phase 2Completed

Seasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S) - PHASE 2/3

Role: collaborator

NCT01507779Phase 1Completed

Safety Trial of Monovalent Whole Virus Influenza (H1N1) Vaccine

Role: collaborator

All 4 trials loaded